The Correct Use Of Biologically Active Supplements In Toxic Hepatitis

Toxic hepatitis, an inflammatory condition of the liver caused by exposure to toxins, presents a significant health challenge. While conventional treatments focus on removing the causative agent and supporting liver function, the potential role of biologically active supplements (BAS) in managing and mitigating the effects of toxic hepatitis is gaining attention. This paper examines the current understanding of toxic hepatitis and the rationale for using BAS. It explores the types of BAS, including antioxidants, hepatoprotective agents, and anti-inflammatory compounds, that may offer therapeutic benefits in the context of toxic liver injury. The study analyzes the existing evidence regarding the efficacy, safety, and appropriate use of these supplements, highlighting the importance of a personalized and evidence-based approach. It also emphasizes the necessity of understanding potential interactions with conventional treatments and the need for further research to clarify the optimal role of BAS in the management of toxic hepatitis

Authors

Institutions

Publication Details

Journal
Texas Journal of Medical Science
Published
2024-12-28
DOI
https://doi.org/10.62480/tjms.2024.vol39.pp93-95
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Correct Use Of Biologically Active Supplements In Toxic Hepatitis

Abdullayeva Mavsumakhon Qo'ldashevna
Texas Journal of Medical Science
Drug-Induced Hepatotoxicity and Protection
article

The Correct Use Of Biologically Active Supplements In Toxic Hepatitis

Abdullayeva Mavsumakhon Qo'ldashevna
article en

Abstract

Toxic hepatitis, an inflammatory condition of the liver caused by exposure to toxins, presents a significant health challenge. While conventional treatments focus on removing the causative agent and supporting liver function, the potential role of biologically active supplements (BAS) in managing and mitigating the effects of toxic hepatitis is gaining attention. This paper examines the current understanding of toxic hepatitis and the rationale for using BAS. It explores the types of BAS, including antioxidants, hepatoprotective agents, and anti-inflammatory compounds, that may offer therapeutic benefits in the context of toxic liver injury. The study analyzes the existing evidence regarding the efficacy, safety, and appropriate use of these supplements, highlighting the importance of a personalized and evidence-based approach. It also emphasizes the necessity of understanding potential interactions with conventional treatments and the need for further research to clarify the optimal role of BAS in the management of toxic hepatitis

Texas Journal of Medical ScienceVol. 39
Kurgan State University (RU)
Good health and well-being
Openalex Percentile: Top 67%
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.